Solid lipid nanoparticle induced apoptosis of macrophages via a mitochondrial-dependent pathway in vitro and in vivo

References

• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:2. doi:10.3390/pharmaceutics10020057
   Web of Science ®Google Scholar
• Choi YH, Han HK. Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics. J Pharm Investig. 2018;48(1):43–60. doi:10.1007/s40005-017-0370-4
   PubMedGoogle Scholar
• Palmer BC, DeLouise LA. Nanoparticle-enabled transdermal drug delivery systems for enhanced dose control and tissue targeting. Molecules. 2016;21:12. doi:10.3390/molecules21121719
   Web of Science ®Google Scholar
• Raemdonck K, Braeckmans K, Demeester J, De Smedt SC. Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery. Chem Soc Rev. 2014;43(1):444–472. doi:10.1039/c3cs60299k24100581
   PubMed Web of Science ®Google Scholar
• Lim SB, Banerjee A, Onyuksel H. Improvement of drug safety by the use of lipid-based nanocarriers. J Control Release. 2012;163(1):34–45. doi:10.1016/j.jconrel.2012.06.00222698939
   PubMed Web of Science ®Google Scholar
• Onoue S, Yamada S, Chan HK. Nanodrugs: pharmacokinetics and safety. Int J Nanomedicine. 2014;9:1025–1037. doi:10.2147/IJN.S3837824591825
   PubMed Web of Science ®Google Scholar
• Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm. 2010;385(1–2):113–142. doi:10.1016/j.ijpharm.2009.10.01819825408
   PubMed Web of Science ®Google Scholar
• Yao M, Xiao H, McClements DJ. Delivery of lipophilic bioactives: assembly, disassembly, and reassembly of lipid nanoparticles. Annu Rev Food Sci Technol. 2014;5:53–81. doi:10.1146/annurev-food-072913-10035024328432
   PubMed Web of Science ®Google Scholar
• Lin Q, Chen J, Zhang Z, Zheng G. Lipid-based nanoparticles in the systemic delivery of siRNA. Nanomedicine (Lond). 2014;9(1):105–120. doi:10.2217/nnm.13.19224354813
   PubMedGoogle Scholar
• Kauffman KJ, Dorkin JR, Yang JH, et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 2015;15(11):7300–7306. doi:10.1021/acs.nanolett.5b0249726469188
   PubMed Web of Science ®Google Scholar
• Charoenputtakun P, Pamornpathomkul B, Opanasopit P, Rojanarata T, Ngawhirunpat T. Terpene composited lipid nanoparticles for enhanced dermal delivery of all-trans-retinoic acids. Biol Pharm Bull. 2014;37(7):1139–1148.24805206
   PubMed Web of Science ®Google Scholar
• Weber S, Zimmer A, Pardeike J. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art. Eur J Pharm Biopharm. 2014;86(1):7–22.24007657
   PubMed Web of Science ®Google Scholar
• Gainza G, Pastor M, Aguirre JJ, et al. A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: in vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice. J Control Release. 2014;185:51–61. doi:10.1016/j.jconrel.2014.04.03224794895
   PubMed Web of Science ®Google Scholar
• Zhang WK, Gu HW, Li XJ, et al. The dark side of “the force” – lipid nanoparticles enhance the oncogenesis of diethylnitrosamine and result in liver cancer in mice. Nanomedicine. 2017;13(2):701–711. doi:10.1016/j.nano.2016.09.01727729235
   PubMedGoogle Scholar
• Seki E, Tsutsui H, Iimuro Y, et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology. 2005;41(3):443–450. doi:10.1002/hep.2060315723296
   PubMedGoogle Scholar
• Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol. 2010;10(11):753–766. doi:10.1038/nri285820972472
   PubMed Web of Science ®Google Scholar
• Tsutsui H, Nishiguchi S. Importance of Kupffer cells in the development of acute liver injuries in mice. Int J Mol Sci. 2014;15(5):7711–7730. doi:10.3390/ijms1505771124802875
   PubMedGoogle Scholar
• Ju C, Reilly TP, Bourdi M, et al. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol. 2002;15(12):1504–1513.12482232
   PubMed Web of Science ®Google Scholar
• Ramachandran P, Iredale JP. Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol. 2012;56(6):1417–1419. doi:10.1016/j.jhep.2011.10.02622314426
   PubMedGoogle Scholar
• Chiang DJ, Pritchard MT, Nagy LE. Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;300(5):G697–G702. doi:10.1152/ajpgi.00426.201021350183
   PubMed Web of Science ®Google Scholar
• Zhao X, Qi C, Li Y, Tang H, Wei L, Yang X. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur J Pharm Biopharm. 2015;93:27–36. doi:10.1016/j.ejpb.2015.03.00325770771
   PubMed Web of Science ®Google Scholar
• Xiaojing Zhao QC, Liu W, Li Y, Tang H, Liu X, Yang X. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer. Int J Nanomedicine. 2015;10(default):257–270. doi:10.2147/IJN.S7332225565818
   PubMedGoogle Scholar
• Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958–969. doi:10.1038/nri244819029990
   PubMed Web of Science ®Google Scholar
• Dixon LJ, Barnes M, Tang H, Pritchard MT, Nagy LE. Kupffer cells in the liver. Compr Physiol. 2013;3(2):785–797. doi:10.1002/cphy.c12002623720329
   PubMed Web of Science ®Google Scholar